Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study on Cerebral Malaria Could Lead to Diagnostic Test

By Biotechdaily staff writers
Posted on 16 May 2007
The results of a study on children in Gabonese hospitals show that, in 90% of children suffering from cerebral malaria, antibodies specifically recognize a protein in the brain--cerebral alpha-spectrin.

The study provides a lead on how to perfect a diagnostic test, which should allow for better patient care. More...
Scientists at Centre National de la Recherche Scientifique (CNRS; Paris France) and the Pasteur Institute (Paris, France) collaborating with physicians in Gabon, have just undertaken a study on cerebral malaria in children living in an endemic region. This study, which was published in the April 2007 issue of the journal PLoS ONE, should allow clinicians to better understand this severe form of malaria which affects 20-40% of people infected by the Plasmodium falciparum parasite, and is fatal in 30–50% of cases.

A particular immunologic phenomenon has been observed in people infected by P falciparum. The B-lymphocytes, the main antibody-producing cells, increase their secretion of a range of antibodies, notably those directed against various components of the organism (such as DNA and red blood cells). Today, it is still not known if these autoantibodies are the result of pathologic mechanisms associated with the infection or if they contribute to the events leading to severe forms of the illness.

The French and Gabonese teams sought to understand if some of these autoantibodies were directed against the molecules in the brain. They worked on the blood samples of some 350 children aged between 6 months and five years who had been treated in Gabonese hospitals. The cohort was divided into five groups: control patients (without parasites in the blood), asymptomatic patients, patients developing simple malaria, patients suffering from serious, non-cerebral malaria (notably severe anaemia), and finally patients suffering from neurologic infection. The results of the study showed that in 90% of children suffering from cerebral malaria, the antibodies specifically recognized a protein in the brain, cerebral alpha-spectrin.

This study also opened a new sector of malaria research; understanding the role of autoantibodies directed against cerebral antigens in the development of the illness.


Related Links:
Centre National de la Recherche Scientifique
Pasteur Institute

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.